$GATO
Gatos Silver, Inc.

2022 Q2 Form 10-Q Financial Statement

#000110465923038836 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2022 Q2 2021 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.260M $4.411M
YoY Change -3.42% 82.27%
% of Gross Profit
Research & Development $0.00 $694.0K
YoY Change -100.0% -53.11%
% of Gross Profit
Depreciation & Amortization $50.00K $4.000K
YoY Change 1150.0% -99.66%
% of Gross Profit
Operating Expenses $4.300M $5.112M
YoY Change -15.88% 0.43%
Operating Profit
YoY Change
Interest Expense $8.640M $18.29M
YoY Change -52.76% -324.71%
% of Operating Profit
Other Income/Expense, Net $1.110M $312.0K
YoY Change 255.77% -140.78%
Pretax Income $5.571M $13.49M
YoY Change -58.71% -196.92%
Income Tax $340.0K
% Of Pretax Income 6.1%
Net Earnings -$2.426M $13.49M
YoY Change -117.98% -211.09%
Net Earnings / Revenue
Basic Earnings Per Share -$0.04 $0.23
Diluted Earnings Per Share -$0.04 $0.22
COMMON SHARES
Basic Shares Outstanding 69.16M 59.75M
Diluted Shares Outstanding 69.16M 60.62M

Balance Sheet

Concept 2022 Q2 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.300M $29.61M
YoY Change -75.34% 1380.35%
Cash & Equivalents $7.277M $29.61M
Short-Term Investments
Other Short-Term Assets $2.222M $2.190M
YoY Change 1.46% -35.59%
Inventory
Prepaid Expenses $1.347M
Receivables
Other Receivables
Total Short-Term Assets $10.08M $37.18M
YoY Change -72.91% 139.9%
LONG-TERM ASSETS
Property, Plant & Equipment $48.00K
YoY Change -99.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $342.6M $247.3M
YoY Change 38.52% 170.3%
Other Assets $48.00K $48.00K
YoY Change 0.0% -84.0%
Total Long-Term Assets $374.7M $247.4M
YoY Change 51.46% 173.37%
TOTAL ASSETS
Total Short-Term Assets $10.08M $37.18M
Total Long-Term Assets $374.7M $247.4M
Total Assets $384.8M $284.6M
YoY Change 35.21% 168.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $198.0K $369.0K
YoY Change -46.34% 269.0%
Accrued Expenses $618.0K $2.059M
YoY Change -69.99% -14.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.300M $3.781M
YoY Change -65.62% -70.92%
LONG-TERM LIABILITIES
Long-Term Debt $12.70M $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $12.70M $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.300M $3.781M
Total Long-Term Liabilities $12.70M $0.00
Total Liabilities $14.00M $3.781M
YoY Change 270.27% -73.92%
SHAREHOLDERS EQUITY
Retained Earnings -$174.5M -$135.6M
YoY Change 28.7%
Common Stock $117.0K $108.0K
YoY Change 8.33%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.027M
YoY Change
Treasury Stock Shares $144.6K
Shareholders Equity $370.7M $280.8M
YoY Change
Total Liabilities & Shareholders Equity $384.8M $284.6M
YoY Change 35.21% 109.08%

Cashflow Statement

Concept 2022 Q2 2021 Q2
OPERATING ACTIVITIES
Net Income -$2.426M $13.49M
YoY Change -117.98% -211.09%
Depreciation, Depletion And Amortization $50.00K $4.000K
YoY Change 1150.0% -99.66%
Cash From Operating Activities $2.020M -$1.305M
YoY Change -254.79% -72.93%
INVESTING ACTIVITIES
Capital Expenditures $30.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$2.775M
YoY Change -44.39%
Cash From Investing Activities -$30.00K -$2.775M
YoY Change -98.92% -44.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 2.651M
YoY Change -100.0% -74.04%
NET CHANGE
Cash From Operating Activities 2.020M -1.305M
Cash From Investing Activities -30.00K -2.775M
Cash From Financing Activities 0.000 2.651M
Net Change In Cash 1.990M -1.429M
YoY Change -239.26% -457.25%
FREE CASH FLOW
Cash From Operating Activities $2.020M -$1.305M
Capital Expenditures $30.00K
Free Cash Flow $1.990M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001517006
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39649
dei Entity Registrant Name
EntityRegistrantName
GATOS SILVER, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2654848
dei Entity Address Address Line1
EntityAddressAddressLine1
925 W Georgia Street, Suite 910
dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6C 3L2
dei City Area Code
CityAreaCode
604
dei Local Phone Number
LocalPhoneNumber
424-0984
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
GATO
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69162223
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7277000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6616000
CY2022Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
576000
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1592000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2222000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3558000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
10075000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11766000
CY2022Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
374627000
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
355310000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
48000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35000
CY2022Q2 us-gaap Assets
Assets
384750000
CY2021Q4 us-gaap Assets
Assets
367111000
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1336000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1406000
CY2022Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
12694000
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
12620000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
117000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
117000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
545061000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
543829000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-174458000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-190861000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
370720000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
353085000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
384750000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
367111000
CY2021Q2 us-gaap Exploration Expense
ExplorationExpense
694000
us-gaap Exploration Expense
ExplorationExpense
110000
us-gaap Exploration Expense
ExplorationExpense
918000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4257000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5661000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11034000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10514000
CY2022Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
44000
CY2021Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
88000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
14000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
4301000
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
6362000
us-gaap Costs And Expenses
CostsAndExpenses
11232000
us-gaap Costs And Expenses
CostsAndExpenses
11446000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
765000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
18291000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
25379000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
20992000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1110000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1562000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2256000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2325000
CY2022Q2 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
1875000
CY2021Q2 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
19853000
gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
27635000
gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
23317000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2426000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
13491000
us-gaap Net Income Loss
NetIncomeLoss
16403000
us-gaap Net Income Loss
NetIncomeLoss
11871000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59534627
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59427320
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69162223
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60623496
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60420811
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
353085000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1482000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
18829000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
373396000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-250000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2426000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
370720000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
261386000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1078000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1559000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-262000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1620000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
262141000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2490000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2662000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-7000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
13491000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
280777000
us-gaap Profit Loss
ProfitLoss
16403000
us-gaap Profit Loss
ProfitLoss
11871000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
88000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
14000
us-gaap Share Based Compensation
ShareBasedCompensation
1360000
us-gaap Share Based Compensation
ShareBasedCompensation
3426000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
127000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
44000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
25379000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
20992000
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
13300000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-1016000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
3375000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-198000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-572000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1336000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1689000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8053000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7895000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27000
gato Payments For Proceeds From Acquire Interest In Subsidiaries And Affiliates
PaymentsForProceedsFromAcquireInterestInSubsidiariesAndAffiliates
7365000
gato Payments For Proceeds From Acquire Interest In Subsidiaries And Affiliates
PaymentsForProceedsFromAcquireInterestInSubsidiariesAndAffiliates
116595000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7392000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-116595000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
269000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4221000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3951000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
661000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-120539000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6616000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150146000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7277000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29607000
us-gaap Interest Paid Net
InterestPaidNet
227000
gato Deferred Financing Costs Included In Accounts Payable And Accrued Liabilities
DeferredFinancingCostsIncludedInAccountsPayableAndAccruedLiabilities
284000
CY2022Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
655000
CY2021Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
575000
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1347000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2976000
CY2022Q2 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
220000
CY2021Q4 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
7000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2222000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3558000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
198000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
196000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
618000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
623000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
520000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
587000
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1336000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1406000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1700000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
-228000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2287000
us-gaap Share Based Compensation
ShareBasedCompensation
1360000
us-gaap Share Based Compensation
ShareBasedCompensation
3426000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2426000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
13491000
us-gaap Net Income Loss
NetIncomeLoss
16403000
us-gaap Net Income Loss
NetIncomeLoss
11871000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59534627
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59427320
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
876448
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
809749
CY2021Q2 gato Incremental Common Shares Attributable To Dilutive Effect Of Deferred Share Units
IncrementalCommonSharesAttributableToDilutiveEffectOfDeferredShareUnits
212421
gato Incremental Common Shares Attributable To Dilutive Effect Of Deferred Share Units
IncrementalCommonSharesAttributableToDilutiveEffectOfDeferredShareUnits
146796
gato Incremental Common Shares Attributable To Dilutive Effect Of Deferred Share Units
IncrementalCommonSharesAttributableToDilutiveEffectOfDeferredShareUnits
183742
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69162223
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60623496
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60420811
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2021Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
50000000
CY2021Q3 gato Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity
100000000
CY2021Q3 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
13000000
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
9000000
CY2022Q4 gato Line Of Credit Facility Decrease In Maximum Borrowing Capacity
LineOfCreditFacilityDecreaseInMaximumBorrowingCapacity
50000000
CY2021Q2 us-gaap Exploration Expense
ExplorationExpense
694000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4257000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5661000
CY2022Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
44000
CY2021Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
765000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
18291000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1110000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1562000
CY2022Q2 us-gaap Assets
Assets
384750000
CY2021Q2 us-gaap Assets
Assets
284558000
us-gaap Exploration Expense
ExplorationExpense
110000
us-gaap Exploration Expense
ExplorationExpense
918000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11034000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10514000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
88000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
14000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
25379000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
20992000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2256000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2325000
CY2022Q2 us-gaap Assets
Assets
384750000
CY2021Q2 us-gaap Assets
Assets
284558000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001104659-23-038836-index-headers.html Edgar Link pending
0001104659-23-038836-index.html Edgar Link pending
0001104659-23-038836.txt Edgar Link pending
0001104659-23-038836-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gato-20220630.xsd Edgar Link pending
gato-20220630x10q.htm Edgar Link pending
gato-20220630x10q003.jpg Edgar Link pending
gato-20220630xex31d1.htm Edgar Link pending
gato-20220630xex31d2.htm Edgar Link pending
gato-20220630xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
gato-20220630_cal.xml Edgar Link unprocessable
gato-20220630_lab.xml Edgar Link unprocessable
gato-20220630_pre.xml Edgar Link unprocessable
gato-20220630x10q_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gato-20220630_def.xml Edgar Link unprocessable